Showing results (141-150 of 247) with videos related to
Sort By:
Pageof 25
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 24, 2024
Perioperative safety and oncological efficacy of simultaneous versus colorectal and liver first two-staged resections in patients with synchronous colorectal liver metastases: a systematic review and network meta-analysisJasper P Sijberden, Maria S Alvarez Escribano, Meidai Kasai, et al.Journal of the National Cancer Institute|May 20, 2004
Randomized trial of intraportal and/or systemic adjuvant chemotherapy in patients with colon carcinomaRoberto Labianca, Roldano Fossati, Alberto Zaniboni, et al.Oncotarget|September 4, 2015
Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: implications for clinical managementMichela Del Prete, Riccardo Giampieri, Fotios Loupakis, et al.Med (New York, N.Y.)|June 29, 2026
Advanced cholangiocarcinoma in 2025: Therapeutic sequencing and global implementationFausto Petrelli, Chiara Pesenti, Fulvia Milena Cribiù, et al.Medicina (Kaunas, Lithuania)|February 24, 2024
Different Chemotherapy Regimens and Pathologic Complete Response in Triple-Negative Breast Cancer: An Updated Network Meta-Analysis of Phase 3 TrialsFausto Petrelli, Gianluca Tomasello, Maria Chiara Parati, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2007
Nuclear factor-kB tumor expression predicts response and survival in irinotecan-refractory metastatic colorectal cancer treated with cetuximab-irinotecan therapyMario Scartozzi, Italo Bearzi, Chiara Pierantoni, et al.Tumori|December 16, 2006
Capecitabine and mitomycin C may be an effective treatment option for third-line chemotherapy in advanced colorectal cancerMario Scartozzi, Alfredo Falcone, Francesca Pucci, et al.European Journal of Cancer (Oxford, England : 1990)|December 11, 2008
Incidence and clinical implications of venous thromboembolism in advanced colorectal cancer patients: the 'GISCAD-alternating schedule' study findingsMario Mandalà, Sandro Barni, Irene Floriani, et al.Cancer|October 25, 2011
Final results of a phase 2A study for the treatment of metastatic neuroendocrine tumors with a fixed activity of 90Y-DOTA-D-Phe1-Tyr3 octreotideGiordano Savelli, Francesco Bertagna, Fabio Franco, et al.Critical Reviews in Oncology/Hematology|May 21, 2010
The impact of anemia on quality of life and hospitalisation in elderly cancer patients undergoing chemotherapyLaura Doni, Alessandra Perin, Luigi Manzione, et al.Pageof 25